{
    "id": "nclex_ngn_sa_0098",
    "type": "selectN",
    "stem": "The nurse is preparing to administer the 1600 dose of IV metoprolol. Based on the client's electronic health record, which findings require the nurse to withhold the medication and immediately notify the healthcare provider? Select all that apply.",
    "tabs": [
        {
            "id": "nursesNotes",
            "label": "Nurses' Notes",
            "content": "1400: Client, a 78-year-old male with a history of heart failure with preserved ejection fraction (HFpEF) and hypertension, presents to the emergency department via family car. Reports 'heart racing,' shortness of breath, and dizziness for the past 2 days. States he delayed seeking care due to lack of reliable transportation. Alert and oriented x3. Skin warm and dry. Lungs with fine crackles in bilateral bases. S1, S2 audible, tachycardic and irregularly irregular. 2+ pitting edema in lower extremities. \n\n1600: Called to bedside for increased restlessness. Client appears anxious and fatigued. Skin is now cool and clammy to the touch. Capillary refill is 3 seconds. Client states, 'I feel like something bad is about to happen.'"
        },
        {
            "id": "vitalSigns",
            "label": "Vital Signs",
            "content": [
                {
                    "time": "1400",
                    "BP": "142/88 mmHg",
                    "HR": "148/min",
                    "RR": "24/min",
                    "SpO2": "94% on 2L NC",
                    "Temp": "37.1째C (98.8째F)"
                },
                {
                    "time": "1500",
                    "BP": "110/70 mmHg",
                    "HR": "142/min",
                    "RR": "26/min",
                    "SpO2": "93% on 2L NC",
                    "Temp": "37.0째C (98.6째F)"
                },
                {
                    "time": "1600",
                    "BP": "92/58 mmHg",
                    "HR": "138/min",
                    "RR": "28/min",
                    "SpO2": "92% on 2L NC",
                    "Temp": "N/A"
                }
            ]
        },
        {
            "id": "labResults",
            "label": "Laboratory Results",
            "content": [
                {
                    "lab": "Potassium",
                    "value": "4.1 mEq/L",
                    "range": "3.5-5.0 mEq/L"
                },
                {
                    "lab": "Troponin T",
                    "value": "<0.01 ng/mL",
                    "range": "<0.04 ng/mL"
                },
                {
                    "lab": "BUN",
                    "value": "28 mg/dL",
                    "range": "10-20 mg/dL"
                },
                {
                    "lab": "Creatinine",
                    "value": "1.4 mg/dL",
                    "range": "0.6-1.2 mg/dL"
                },
                {
                    "lab": "Lactate",
                    "value": "4.2 mmol/L",
                    "range": "0.5-2.2 mmol/L"
                }
            ]
        },
        {
            "id": "diagnosticResults",
            "label": "Diagnostic Results",
            "content": "12-Lead ECG Interpretation (1415):\nAtrial fibrillation with a rapid ventricular response (RVR) at a rate of 145/min. No evidence of acute ST-segment changes. Left ventricular hypertrophy noted."
        },
        {
            "id": "mar",
            "label": "MAR",
            "content": [
                {
                    "medication": "Metoprolol Tartrate 5 mg IV Push",
                    "route": "IV Push",
                    "frequency": "every 15 minutes for 3 doses, for HR > 110/min",
                    "timeDue": "1600"
                },
                {
                    "medication": "Heparin Sodium infusion",
                    "route": "IV",
                    "frequency": "per protocol",
                    "timeDue": "N/A"
                }
            ]
        }
    ],
    "options": [
        {
            "id": "opt_C",
            "label": "C",
            "content": "Serum lactate of 4.2 mmol/L"
        },
        {
            "id": "opt_B",
            "label": "B",
            "content": "Blood pressure of 92/58 mmHg"
        },
        {
            "id": "opt_D",
            "label": "D",
            "content": "Irregularly irregular rhythm"
        },
        {
            "id": "opt_A",
            "label": "A",
            "content": "Heart rate of 138/min"
        },
        {
            "id": "opt_F",
            "label": "F",
            "content": "BUN of 28 mg/dL"
        },
        {
            "id": "opt_E",
            "label": "E",
            "content": "Cool, clammy skin"
        }
    ],
    "rationale": {
        "correct": "The client is exhibiting classic signs of decompensation into cardiogenic shock, likely due to the sustained rapid ventricular rate reducing diastolic filling time and cardiac output. The combination of significant hypotension (BP 92/58), clinical signs of hypoperfusion (cool, clammy skin), and biochemical evidence of tissue hypoxia (elevated lactate) constitutes an absolute contraindication to administering a beta-blocker like metoprolol. Metoprolol is a negative chronotrope and inotrope, meaning it would further decrease the heart rate and contractility, catastrophically lowering the already dangerously low blood pressure and cardiac output. The nurse's priority is to recognize this life-threatening change, withhold the medication, and advocate for immediate alternative interventions such as synchronized cardioversion, vasopressors, or different antiarrhythmics.",
        "incorrect": "Selecting options that describe the underlying condition (A-fib with RVR) or chronic/less acute issues demonstrates a failure to recognize the emergent, life-threatening contraindication. While tachycardia and an irregular rhythm are the reasons for the medication order, the new onset of hemodynamic instability makes that order unsafe to carry out. The nurse must differentiate between the problem being treated and the new, more dangerous problem that has developed.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "Heart rate of 138/min",
                "isCorrect": false,
                "justification": "Incorrect. The persistent tachycardia is the indication for the metoprolol, not a contraindication. The goal of the medication is to lower the heart rate. While abnormal, this finding supports the original reason for the order."
            },
            {
                "label": "B",
                "content": "Blood pressure of 92/58 mmHg",
                "isCorrect": true,
                "justification": "Correct. This significant drop in blood pressure from the baseline of 142/88 mmHg indicates hemodynamic instability. Administering a beta-blocker, which lowers blood pressure and cardiac output, to a hypotensive client is extremely dangerous and can precipitate cardiovascular collapse."
            },
            {
                "label": "C",
                "content": "Serum lactate of 4.2 mmol/L",
                "isCorrect": true,
                "justification": "Correct. An elevated lactate level is a critical indicator of anaerobic metabolism due to systemic hypoperfusion (shock). This biochemical evidence confirms that the client's organs are not receiving adequate oxygen. This is a key sign that administering a medication that further reduces cardiac output is contraindicated."
            },
            {
                "label": "D",
                "content": "Irregularly irregular rhythm",
                "isCorrect": false,
                "justification": "Incorrect. This is the hallmark rhythm of atrial fibrillation. It describes the underlying pathology for which the client is being treated. It is an expected finding, not a reason to withhold rate-control medication."
            },
            {
                "label": "E",
                "content": "Cool, clammy skin",
                "isCorrect": true,
                "justification": "Correct. This is a classic clinical sign of peripheral vasoconstriction, a compensatory mechanism in shock. It indicates that the body is shunting blood from the extremities to the vital organs due to poor cardiac output. This new physical assessment finding is a major red flag for decompensation."
            },
            {
                "label": "F",
                "content": "BUN of 28 mg/dL",
                "isCorrect": false,
                "justification": "Incorrect. While an elevated BUN (and creatinine) can suggest renal hypoperfusion or a pre-existing renal issue, it is not an acute, absolute contraindication for a single dose of IV metoprolol. It is a concerning piece of data, but the hypotension and signs of shock are the immediate life-threatening contraindications that require stopping the action."
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "Analyzing",
        "cjmmStep": "Take Actions",
        "nclexCategory": "Reduction of Risk Potential",
        "nclexSubCategory": "Potential for Complications of Diagnostic Tests/Treatments/Procedures",
        "difficulty": "Hard",
        "topicTags": [
            "Atrial Fibrillation",
            "Cardiogenic Shock",
            "Medication Safety",
            "Contraindication",
            "Metoprolol",
            "Hemodynamic Instability"
        ]
    }
}